Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing

Bead-free microbubble approach aims to simplify cell selection and activation for scalable cell therapy manufacturing

February 13, 2026
3 min

The Medicine Maker

Objective:

To introduce a microbubble-based approach for cell selection and activation in cell therapy manufacturing, replacing traditional magnetic beads.

Key Findings:

Microbubbles can enhance the isolation of immune cell subsets beyond standard CD3+ selection.
The approach minimizes perturbation of intracellular signaling pathways, providing a cleaner starting point for genetic modification.
Microbubbles can be easily removed, simplifying workflows compared to bead-based processes.

Interpretation:

Bracco's microbubble technology aims to address key challenges in cell therapy manufacturing by providing a more efficient, scalable, and cleaner method for cell selection and activation.

Limitations:

The technology is still in the development phase and requires performance validation through partnerships.
Commercial availability is projected for 2027, which may limit immediate application.

Conclusion:

Bracco's innovative microbubble platform has the potential to revolutionize cell therapy manufacturing by offering a more efficient and less invasive alternative to traditional methods.

Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing

Objective:

Key Findings:

Interpretation:

Limitations:

Conclusion:

Original Source(s)

Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing

Related Content

Surgical outcomes of Bethesda System for Reporting Thyroid Cytopathology diagnostic category class I, II, and III thyroid nodules

The Impact of Physical Activity Levels on Sexual Function in Breast Cancer Survivors: An Integrative Review

Pathogenic germline variations and cancer risks in pediatric patients referred for genetic testing